SCHEMBL28676540

SCHEMBL28676540

COc1cccc(N)c1-c1c(F)cc2c(c1F)OC[C@H]1CN(C(=O)O)CCN1C2

nearest known ligand 0.58

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
KRAS P01116 17/20 0.58
MGLL Q99685 2/20 0.36
KCNJ1 P48048 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28658817 0.92 KRAS (0.66) KRASMGLL
SCHEMBL28659228 0.90 KRAS (0.56) KRASMGLL
SCHEMBL24558262 0.90 KRAS (0.54) KRAS
SCHEMBL29693086 0.90 KRAS (0.54) KRAS
SCHEMBL28658799 0.89 KRAS (0.55) KRASKCNJ1
SCHEMBL28668876 0.88 KRAS (0.55) KRASMGLL
SCHEMBL28670544 0.88 KRAS (0.61) KRASMGLL
SCHEMBL31107247 0.82 KRAS (0.61) KRAS
SCHEMBL24558440 0.82 KRAS (0.61) KRAS
SCHEMBL28655430 0.81 KRAS (0.56) KRASMGLL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113508118-A Fused tricyclic compounds useful as anticancer agents 阿斯利康(瑞典)有限公司 2021-10-15 CN disclosed